Skip to content
10-Q

Quarterly Report

BIOGEN INC. BIIB

0000875045-26-000045

← back to feed
Filed
Apr 29, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 27, 2026 147.64M sh
Shares Diluted Q1 2026 · Mar 31, 2026 148.4M sh
Shares Diluted Q1 2026 · Mar 31, 2025 146.6M sh
Capex Q1 2026 · Mar 31, 2026 $51.2M
Capex Q1 2026 · Mar 31, 2025 $37.1M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $645.5M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $259.3M
Long Term Debt Q1 2026 · Mar 31, 2026 $6.29B
Long Term Debt Q1 2026 · Dec 31, 2025 $6.29B
Current Liabilities Q1 2026 · Mar 31, 2026 $3B
Current Liabilities Q1 2026 · Dec 31, 2025 $3.35B
Total Liabilities Q1 2026 · Mar 31, 2026 $10.83B
Total Liabilities Q1 2026 · Dec 31, 2025 $11.18B
Current Assets Q1 2026 · Mar 31, 2026 $9.19B
Current Assets Q1 2026 · Dec 31, 2025 $8.97B
Total Assets Q1 2026 · Mar 31, 2026 $29.48B
Total Assets Q1 2026 · Dec 31, 2025 $29.44B
Eps Diluted Q1 2026 · Mar 31, 2026 $2.15
Eps Diluted Q1 2026 · Mar 31, 2025 $1.64
Eps Basic Q1 2026 · Mar 31, 2026 $2.17
Eps Basic Q1 2026 · Mar 31, 2025 $1.65
Sga Expense Q1 2026 · Mar 31, 2026 $607.3M
Sga Expense Q1 2026 · Mar 31, 2025 $572.5M
Net Income Q1 2026 · Mar 31, 2026 $319.5M
Net Income Q1 2026 · Mar 31, 2025 $240.5M
Revenue Q1 2026 · Mar 31, 2026 $2.48B
Revenue Q1 2026 · Mar 31, 2025 $2.43B